One Stop Shop for All Your Market Research Reports

Global Influenza Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. The CDC estimates that vaccination against influenza reduces sickness, medical visits, hospitalizations, and deaths. When an immunized worker does catch the flu, they are on average back at work a half day sooner. Vaccine effectiveness in those under two years old and over 65 years old remains unknown due to the low quality of the research. needs update][8][needs update] Vaccinating children may protect those around them. The World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) recommend yearly vaccination for nearly all people over the age of six months, especially those at high risk. The European Centre for Disease Prevention and Control also recommends yearly vaccination of high risk groups. These groups include pregnant women, the elderly, children between six months and five years of age, those with other health problems, and those who work in healthcare. The vaccines are generally safe. Fever occurs in five to ten percent of children vaccinated. Temporary muscle pains or feelings of tiredness may occur as well. In certain years, the vaccine has been linked to an increase in Guillain?Barr? syndrome among older people at a rate of about one case per million doses. It should not be given to those with severe allergies to eggs or to previous versions of the vaccine. The vaccines come in both inactive and weakened viral forms. The inactive version should be used for those who are pregnant. They come in forms that are injected into a muscle, sprayed into the nose, or injected into the middle layer of the skin. Vaccination against influenza began in the 1930s with large scale availability in the United States beginning in 1945. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale price in the developing world is about $5.25 USD per dose as of 2014.In the United States, it costs less than $25 USD as of 2015. Scope of the Report: This report focuses on the Influenza Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The worldwide market for Influenza Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. Market Segment by Manufacturers, this report covers AstraZeneca CSL GlaxoSmithKline Sanofi Altimmune BionVax FluGen FOLIA BIOTECH Genentech Green Cross Medicago Moderna Therapeutics Novavax Shijiazhuang Yiling Pharmaceutical SK Chemicals UNM Pharma Vaccitech Vaxart Vaxine Pty Visterra Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Trivalent Flu Vaccines Quadrivalent Flu Vaccines Market Segment by Applications, can be divided into Adults Pediatrics There are 15 Chapters to deeply display the global Influenza Vaccines market. Chapter 1, to describe Influenza Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Influenza Vaccines, with sales, revenue, and price of Influenza Vaccines, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Influenza Vaccines, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions; Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018; Chapter 12, Influenza Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023; Chapter 13, 14 and 15, to describe Influenza Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents 1 Market Overview 1.1 Influenza Vaccines Introduction 1.2 Market Analysis by Type 1.2.1 Trivalent Flu Vaccines 1.2.2 Quadrivalent Flu Vaccines 1.3 Market Analysis by Applications 1.3.1 Adults 1.3.2 Pediatrics 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3480
Multi User US $5220
Corporate User US $6960
About this Report
Report ID 306877
Category
  • Pharmaceuticals and Healthcare
Published on 31-Aug
Number of Pages 150
Publisher Name Global Info Research
Editor Rating
★★★★★
★★★★★
(34)